Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Antifungal Locks to Treat Fungal-related Central Line Infections
Phase 4
Completed
- Conditions
- Central Line Fungal Infections
- Interventions
- Drug: amphotericin B liposomal (Ambisome)
- First Posted Date
- 2009-07-10
- Last Posted Date
- 2017-10-10
- Lead Sponsor
- Bill McGhee
- Target Recruit Count
- 13
- Registration Number
- NCT00936910
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
News
No news found